Encorium Reports 2nd QTR 2009 Net Revenue of 4.5 Million (Company Overview) (Financial Report‪)‬

Encorium Group, Inc. (NASDAQ:ENCO), Wayne, Pa., a full service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceutical companies, has announced its financial results for the second quarter ended June 30, 2009. As previously announced, on July 16, 2009 the company sold substantially all of the assets relating to its US line of business to Pierrel Research USA, Inc., the result of which the company no longer has any employees or significant operations in the United States. Due to this sale, for the six months ended June 30, 2009 and 2008, the results of the U.S. business have been presented as discontinued operations in the company's consolidated financial statements.